8-K 1 f27716e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: February 22, 2007
(Date of earliest event reported)
OCULUS INNOVATIVE SCIENCES, INC.
 
(Exact name of registrant as specified in its charter)
         
Delaware   001-33216   68-0423298
(State or Other Jurisdiction
of Incorporation) 		  (Commission File Number)   (I.R.S. Employer
Identification Number)
     
1129 N. McDowell Blvd.    
Petaluma, California   94954
(Address of principal executive offices)   (Zip Code)
(707) 782-0792
(Registrant’s telephone number,
 
including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
o
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
SIGNATURE
Exhibit Index
EXHIBIT 99.1

Table of Contents

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On February 22, 2007, Oculus Innovative Sciences, Inc. issued a press release announcing financial results for its third fiscal quarter ended December 31, 2006. The full text of the press release is furnished as Exhibit 99.1.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
                 
 
  (d)   Exhibits    
 
                
 
        99.1     Press release issued by Oculus Innovative Sciences, Inc. dated February 22, 2007.

 

Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     Dated: February 22 , 2007
         
  OCULUS INNOVATIVE SCIENCES, INC.
 		  
  By:   /S/ Robert Miller   
    Robert Miller   
    Chief Financial Officer
(title) 		  

 

Table of Contents

         
Exhibit Index
     
99.1
  Press release issued by Oculus Innovative Sciences, Inc. dated February 22, 2007.